{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-26-000194","form_type":"8-K","ticker":"VANI","cik":"0001266806","company_name":"Vivani Medical, Inc.","filed_at":"2026-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.681512+00:00","generated_at":"2026-05-16T07:27:16.547091+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Vivani Medical prices $4.5M common stock offering; Chairman participates in private placement","bullets":["Gross proceeds of $4.5M from registered direct offering (1.69M shares) and private placement (1.35M shares) at $1.48/share.","Chairman Gregg Williams purchased 1,351,351 shares in private placement at same price.","Net proceeds to fund clinical development and working capital; offering expected to close Jan. 27, 2026.","ThinkEquity acted as sole placement agent for the registered direct offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-26-000194","json":"https://secwatch.observer/filing/0001753926-26-000194.json","markdown":"https://secwatch.observer/filing/0001753926-26-000194.md","text":"https://secwatch.observer/filing/0001753926-26-000194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/0001753926-26-000194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/vani-20260125.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T07:27:16.547091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f76f3c31b7ad939047a70cb7724dc7745e81cca","claim":"Vivani Medical, Inc. issued 1,351,351 shares of common stock of common stock to entity affiliated with Gregg Williams, Chairman of the Company’s board of directors for purchase price of $1.48 per share, gross proceeds of approximately $2.0 million.","evidence_excerpt":"Vivani Medical, Inc. (the “Company”) entered into a Share Purchase Agreement, dated January 25 , 2026 (the “Purchase Agreement”), with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”) for the purchase of an aggregate of 1,351,351 shares of common stock, par value of $0.0001 per share (“Common Stock”) of the Company at a purchase price of $1. 4 8 per share (the “Private Placement Shares”), the last reported sale price of the Common Stock on January 2 3 , 2026 . This private placement of Common Stock resulted in gross proceeds of approximately $ 2.0 million to the Company.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/0001753926-26-000194-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"1,351,351 shares of common stock"},{"label":"Purchaser","value":"entity affiliated with Gregg Williams, Chairman of the Company’s board of directors"},{"label":"Consideration","value":"purchase price of $1.48 per share, gross proceeds of approximately $2.0 million"}],"fact_type":"equity_issuance"},{"claim_id":"4832f77ebffed9ea79c9b474f3053e24c56eb881","claim":"Vivani Medical, Inc. entered into Share Purchase Agreement with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”) valued at gross proceeds of approximately $2.0 million (effective 2026-01-25).","evidence_excerpt":"Vivani Medical, Inc. (the “Company”) entered into a Share Purchase Agreement, dated January 25 , 2026 (the “Purchase Agreement”), with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”) for the purchase of an aggregate of 1,351,351 shares of common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/0001753926-26-000194-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors (the “Purchaser”)"},{"label":"Value","value":"gross proceeds of approximately $2.0 million"},{"label":"Effective","value":"2026-01-25"}],"fact_type":"material_agreement"},{"claim_id":"f8177c5d0f41e514a97ee4604ee7c575f303297f","claim":"Vivani Medical, Inc. entered into Placement Agency Agreement with ThinkEquity LLC (the “Agent”) valued at gross proceeds of approximately $2.5 million (effective 2026-01-25).","evidence_excerpt":"the Company also entered into a Placement Agency Agreement, dated January 25 , 2026 (the “Placement Agency Agreement”) with ThinkEquity LLC (the “Agent”) relating to the sale by the Company of 1,689,200 shares of the Company’s Common Stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1266806/000175392626000194/0001753926-26-000194-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"ThinkEquity LLC (the “Agent”)"},{"label":"Value","value":"gross proceeds of approximately $2.5 million"},{"label":"Effective","value":"2026-01-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}